GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (CHIX:JNJd) » Definitions » Cyclically Adjusted Price-to-FCF

Johnson & Johnson (CHIX:JNJD) Cyclically Adjusted Price-to-FCF : 18.73 (As of May. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted Price-to-FCF?

As of today (2024-05-20), Johnson & Johnson's current share price is €136.34. Johnson & Johnson's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €7.28. Johnson & Johnson's Cyclically Adjusted Price-to-FCF for today is 18.73.

The historical rank and industry rank for Johnson & Johnson's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

CHIX:JNJd' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 18.59   Med: 22.9   Max: 27.31
Current: 19.67

During the past years, Johnson & Johnson's highest Cyclically Adjusted Price-to-FCF was 27.31. The lowest was 18.59. And the median was 22.90.

CHIX:JNJd's Cyclically Adjusted Price-to-FCF is ranked better than
68.9% of 328 companies
in the Drug Manufacturers industry
Industry Median: 33.52 vs CHIX:JNJd: 19.67

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Johnson & Johnson's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €1.079. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €7.28 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted Price-to-FCF Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.38 25.29 24.76 23.77 20.21

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.47 21.84 20.31 20.21 20.12

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted Price-to-FCF falls into.



Johnson & Johnson Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Johnson & Johnson's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=136.34/7.28
=18.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Johnson & Johnson's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.079/131.7762*131.7762
=1.079

Current CPI (Mar. 2024) = 131.7762.

Johnson & Johnson Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.201 100.560 1.574
201409 1.057 100.428 1.387
201412 0.887 99.070 1.180
201503 0.761 99.621 1.007
201506 1.491 100.684 1.951
201509 1.698 100.392 2.229
201512 1.219 99.792 1.610
201603 0.496 100.470 0.651
201606 1.213 101.688 1.572
201609 1.479 101.861 1.913
201612 1.906 101.863 2.466
201703 0.799 102.862 1.024
201706 1.650 103.349 2.104
201709 1.678 104.136 2.123
201712 1.499 104.011 1.899
201803 0.875 105.290 1.095
201806 1.637 106.317 2.029
201809 1.713 106.507 2.119
201812 1.588 105.998 1.974
201903 0.947 107.251 1.164
201906 1.680 108.070 2.049
201909 2.306 108.329 2.805
201912 1.730 108.420 2.103
202003 0.926 108.902 1.121
202006 0.929 108.767 1.126
202009 2.432 109.815 2.918
202012 2.161 109.897 2.591
202103 1.068 111.754 1.259
202106 1.398 114.631 1.607
202109 2.397 115.734 2.729
202112 1.430 117.630 1.602
202203 1.148 121.301 1.247
202206 1.673 125.017 1.763
202209 2.024 125.227 2.130
202212 1.339 125.222 1.409
202303 0.858 127.348 0.888
202306 1.075 128.729 1.100
202309 2.397 129.860 2.432
202312 2.189 129.419 2.229
202403 1.079 131.776 1.079

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (CHIX:JNJd) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Johnson & Johnson Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (CHIX:JNJD) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson (CHIX:JNJD) Headlines

No Headlines